Andere talen Hanmi Pharm. Co., Ltd.

Aandelen

A128940

KR7128940004

slotkoers Korea S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
316.500 ^KRW	-0,63%		+0,96%	-10,21%

19/03	Hanmi Pharm. Co. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023	CI
2023	Hanmi Pharm. Co., Ltd. Rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Aptose Biosciences Inc. announced that it has received $4 million in funding from Hanmi Pharm. Co., Ltd.	31/01
Aptose Biosciences Inc. announced that it expects to receive $4 million in funding from Hanmi Pharm. Co., Ltd.	25/01
Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Allergic Rhinitis Pipeline, Clinical Trials, Key Companies	08/11
Hanmi Pharm's Q3 Income Surges 94%	02/11
Allergic Rhinitis Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 (Updated)	28-09-23
AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib First-in-Class Candidate for the Treatment of Intermediate Dry AMD	26-09-23
Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11-08-23
Aptose Biosciences Inc. announced that it expects to receive $6.999998 million in funding from Hanmi Pharm. Co., Ltd.	10-08-23
Hanmi Pharm's Net Income Declines in Q2	01-08-23
Assertio Holdings, Inc. (NasdaqCM : ASRT) completed the acquisition of Spectrum Pharmaceuticals, Inc. (NasdaqGS : SPPI).	31-07-23
Hanmi Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Hanmi Pharm's Net Income Climbs in Q1	27-04-23
Assertio Holdings, Inc. (NasdaqCM : ASRT) entered into a definitive agreement to acquire Spectrum Pharmaceuticals, Inc. (NasdaqGS : SPPI) for approximately $250 million.	25-04-23
Hanmi Pharm. Co., Ltd.'s Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirms Non-inferiority Efficacy and Safety Compared to Monotherapy in The Lancet' & 'European Heart Journal	17-03-23
Advanced Gastric Carcinoma Pipeline Assessment of Active Pipeline Assets Segmented by Stage, Product Type, Route of Administration, and Molecule Type	14-03-23
Hanmi Pharm's Net Income Plunges 23.7% in Q4	09-02-23
Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14-11-22
Hanmi Pharm's Net Profit Jumps 11.5% in Q3	02-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Hanmi Pharm. Co., Ltd.

Aandelen

A128940

KR7128940004

Andere talen

Filters